Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Elanco Animal Health reported quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.27 per share. — An earnings beat of nearly 26% typically triggers a positive short-term price reaction for the specific ticker.
+0.40Elanco Animal Health reported quarterly revenues of $1.37 billion, surpassing the Zacks Consensus Estimate by 4.41%. — Revenue growth and a beat against estimates indicate improving top-line performance and market share.
+0.30Elanco Animal Health has surpassed consensus EPS and revenue estimates four times over the last four quarters. — A consistent track record of beats suggests a pattern of conservative guidance or operational efficiency, reducing risk for investors.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
The company beat both earnings and revenue estimates, delivering a positive earnings surprise of 25.93%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
